-
Validation of Primary Care Resource Use and Costs in OMOP-Mapped vs. Source CPRD Aurum Data
Sep 22, 2025, 16:24 PM -
Real-World Evidence of Healthcare Resource Utilization in Cystic Fibrosis (CF) Patients Treated With Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in France Using Long-term Data From the SNDS Database Linked to the French CF Registry: Findings From...
Sep 22, 2025, 16:24 PM -
Mixed-Method Exploration of Visual Analogue Scale (VAS) Variations to Measure Health, Social Care, and Carer-Related Quality of Life (QoL)
Sep 22, 2025, 16:24 PM -
The Frequency of Mentions and Impact of Patient Input in HTA Decision Making in Cell and Gene Therapies Across the UK, Canada, and Australia
Sep 22, 2025, 16:24 PM -
Treatment Burden and Quality of Life in Patients With nAMD and DME in Colombia: A Mixed Methods Study
Sep 22, 2025, 16:24 PM -
Implementation of Patient Experience Data in Clinical Trial Design: A Literature Review and Semi-Structured Interviews
Sep 22, 2025, 16:24 PM -
Beyond PFS and OS: Recovering Pre- and Post-Progression Survival From Survival Curves
Sep 22, 2025, 16:24 PM -
Cost-Effectiveness Modeling of Test and Treat Strategies: A Diagnosis of Over-Complexity
Sep 22, 2025, 16:24 PM -
Work Productivity Loss in Individuals Due to Respiratory Infections: A Questionnaire Survey of Employees in Denmark
Sep 22, 2025, 16:24 PM -
Advancing Lost Productivity Measurement in Economic Evaluations: Evidence Priorities From a Targeted Literature Review and Multi-Stakeholder Workshop
Sep 22, 2025, 16:24 PM -
Exploring Variability in EQ VAS Scores: A Systematic Review and Meta-Regression of Population Health Studies
Sep 22, 2025, 16:24 PM -
Assessing the Full Life-Cycle Value of Highly Specialized Technologies and Advanced Therapy Medicinal Products in England
Sep 22, 2025, 15:12 PM -
Life-Cycle Economic Modeling to Determine the Evolving Value of a Tumor-Agnostic Precision Oncology Therapy With Conditional Marketing Authorization
Sep 22, 2025, 15:12 PM -
Simulating Sponsor-HTA Conversations: A Multi-Agent GenAI Framework for Reimbursement Processes
Sep 22, 2025, 15:12 PM -
Zoom In: Uncovering Clinical Nuance in Simplified Health Economic Model Structure Through Artificial Intelligence
Sep 22, 2025, 15:12 PM -
Can AI-Assisted Data Extraction From HTA Reports Improve Comparative HTA Research: A Case Study on NICE Assessment Reports
Sep 22, 2025, 15:12 PM -
Predicting EQ-5D Index Scores: A Comparison Study of Machine Learning and Statistical Methods on Health Survey for England Data
Sep 22, 2025, 15:12 PM -
The Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH) in the US: A Total System Value Evidence Framework
Sep 22, 2025, 15:12 PM -
Potential Modifiers of Cost-Effectiveness Thresholds: Public Perspectives on Prioritization in Healthcare Spending
Sep 22, 2025, 15:12 PM -
Cost-Effectiveness of Concurrent Korean and Western Medicine Treatment vs. Usual Care for Car Accident-Related Whiplash Injuries in Korea: A Markov Model Decision Analysis
Sep 18, 2025, 18:38 PM
